Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Holly Williams

AstraZeneca profits jump by 40% amid strong demand for cancer drugs

Drugs giant AstraZeneca has forecast further growth in earnings (PA) - (PA Archive)

Drugs giant AstraZeneca has notched up a 40% surge in annual profits and forecast further growth in earnings over the year ahead as it continues to put faith in strong demand for its cancer treatments.

The FTSE 100 firm reported pre-tax profits of 12.4 billion US dollars (£9.06 billion) for 2025, up from 8.69 billion dollars (£6.35 billion) in 2024, boosted by a 49% jump in the fourth quarter on a constant currency basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.